Novel Treatment Targets for Hemophilia A and AML
This episode features Blood editor Dr. James Griffin interviewing Drs. Vincent Muczynski and Mark Geyer about their research. Dr. Muczynski investigates alternative gene therapy for hemophilia A, while Dr. Geyer explores CAR T cells targeting CD371 for AML treatment.